DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Tolak is a drug marketed by Hill Dermaceuticals and is included in one NDA. There is one patent protecting this drug.
This drug has three patent family members in three countries.
The generic ingredient in TOLAK is fluorouracil. There are fifteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
A generic version of TOLAK was approved as fluorouracil by FRESENIUS KABI USA on September 30th, 1998.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Hill Dermaceuticals||TOLAK||fluorouracil||CREAM;TOPICAL||022259-001||Sep 18, 2015||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|